Your browser doesn't support javascript.
loading
Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition.
Stikvoort, Arwen; Gaballa, Ahmed; Solders, Martin; Nederlof, Iris; Önfelt, Björn; Sundberg, Berit; Remberger, Mats; Sundin, Mikael; Mattsson, Jonas; Uhlin, Michael.
Afiliación
  • Stikvoort A; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Gaballa A; Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.
  • Solders M; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Nederlof I; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Önfelt B; Department of Applied Physics, Royal Institute of Technology, Stockholm, Sweden.
  • Sundberg B; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Remberger M; Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden.
  • Sundin M; Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden; Hematology/Immunology/HSCT Section, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Mattsson J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden.
  • Uhlin M; Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden; Department of Applied Physics, Royal Institute of Technology, Stockholm, Sweden; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Huddinge, Swed
Biol Blood Marrow Transplant ; 24(3): 467-477, 2018 03.
Article en En | MEDLINE | ID: mdl-29197674

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Donantes de Tejidos / Trasplante de Células Madre Hematopoyéticas / Subunidad alfa del Receptor de Interleucina-7 / Receptor de Muerte Celular Programada 1 / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Donantes de Tejidos / Trasplante de Células Madre Hematopoyéticas / Subunidad alfa del Receptor de Interleucina-7 / Receptor de Muerte Celular Programada 1 / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Suecia